Published: 19-12-2022
Review
Chylothorax associated with sarcoidosis: a review of the literature
Abstract 502 | PDF Downloads 423Page e2022039
Original Articles: Clinical Research
Serum Krebs von den Lungen-6: promising biomarker to differentiate CPFE from IPF
Abstract 634 | PDF Downloads 537Page e2022035
Infliximab decreases inflammatory activity but has no effect on small fiber neuropathy related symptoms in Dutch patients with sarcoidosis
Abstract 540 | PDF Downloads 206Page e2022033
Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias
Abstract 888 | PDF Downloads 700Page e2022038
Role of computed tomography findings, complete blood count parameters and systemic inflammatory markers for predicting the severity in interstitial lung diseases
Abstract 666 | PDF Downloads 427Page e2022042
Original Articles: Laboratory Research
Metagenomic sequencing of the bronchoalveolar lavage extracellular virome and cellular transcriptome of sarcoidosis patients does not detect rubella virus
Abstract 543 | PDF Downloads 480Page e2022040
Case Reports
A case of hepatic and bone marrow sarcoidosis with progressive renal failure: diagnostic and therapeutic challenges
Abstract 453 | PDF Downloads 415Page e2022041
Letter to Editor
Management of high-degree atrioventricular block in the setting of cardiac sarcoidosis: A therapeutic controversy
Abstract 419 | PDF Downloads 356Page e2022036
Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis
Abstract 358 | PDF Downloads 337Page e2022037